UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

Circulation (New York, N.Y.), 2016-04, Vol.133 (15), p.1472-1483

2016

Volltextzugriff (PDF)

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices

Cardiovascular and interventional radiology, 2020-01, Vol.43 (1), p.8-19

2020

Volltextzugriff (PDF)

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent

Cardiovascular and interventional radiology, 2021-02, Vol.44 (2), p.196-206

2021

Volltextzugriff (PDF)

Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study

Journal of vascular and interventional radiology, 2018-01, Vol.29 (1), p.9-17.e1

2018

Volltextzugriff (PDF)

First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

Frontiers in cardiovascular medicine, 2022-09, Vol.9, p.877578-877578

2022

Volltextzugriff (PDF)

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm Clinical Studies

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2417-2427

2013

Volltextzugriff (PDF)

Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials

Journal of endovascular therapy, 2014-10, Vol.21 (5), p.644-653

2014

Volltextzugriff (PDF)

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2417-2427

2013

Volltextzugriff (PDF)

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results

JACC. Cardiovascular interventions, 2016-02, Vol.9 (3), p.271-277

2016

Volltextzugriff (PDF)

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results

Cardiovascular and interventional radiology, 2019-03, Vol.42 (3), p.358-364

2019

Volltextzugriff (PDF)

Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study

Journal of endovascular therapy, 2021-04, Vol.28 (2), p.229-235

2021

Volltextzugriff (PDF)

The Roles of Cbl-b and c-Cbl in Insulin-stimulated Glucose Transport

The Journal of biological chemistry, 2003-09, Vol.278 (38), p.36754-36762

2003

Volltextzugriff (PDF)

Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan

Cardiovascular and interventional radiology, 2017-11, Vol.40 (11), p.1669-1677

2017

Volltextzugriff (PDF)

Identification of Steroid-Sensitive Gene-1/Ccdc80 as a JAK2-Binding Protein

Molecular endocrinology (Baltimore, Md.), 2013-04, Vol.27 (4), p.619-634

2013

Volltextzugriff (PDF)

Tu1607 A Randomized Comparison of Degradable Esophageal Stent Versus Dilation Therapy for Patients With Recurrent Benign Esophageal Strictures: 6-Month Results (Destiny Study)

Gastrointestinal endoscopy, 2015-05, Vol.81 (5), p.AB527-AB527

2015

Volltextzugriff (PDF)

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan

JACC. Cardiovascular interventions, 2016-02, Vol.9 (3), p.271-277

2016

Volltextzugriff (PDF)

T-Cell Factor 4N (TCF-4N), a Novel Isoform of Mouse TCF-4, Synergizes with β-Catenin To Coactivate C/EBPα and Steroidogenic Factor 1 Transcription Factors

Molecular and Cellular Biology, 2003-08, Vol.23 (15), p.5366-5375

2003

Volltextzugriff (PDF)

Floodplain Mapping in Response to Surface Mine Reclamation

O'Leary, Erin E

2014

Volltextzugriff (PDF)

T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors

Molecular and cellular biology, 2003-08, Vol.23 (15), p.5366-5375

2003

Volltextzugriff (PDF)

Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

Molecular neurodegeneration, 2010-11, Vol.5 (1), p.45-45, Article 45

2010

Volltextzugriff (PDF)

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark

Annals of surgical oncology, 2018-10, Vol.25 (10), p.2925-2931

2018

Volltextzugriff (PDF)

Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals

The New England journal of medicine, 2018-11, Vol.379 (18), p.1732-1744

2018

Volltextzugriff (PDF)

Controlled Cationic Polymerization: Single-Component Initiation under Ambient Conditions

Journal of the American Chemical Society, 2019-07, Vol.141 (27), p.10605-10609

2019

Volltextzugriff (PDF)

Management of Infants at Risk for Group B Streptococcal Disease

Pediatrics (Evanston), 2019-08, Vol.144 (2)

2019

Volltextzugriff (PDF)

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium

Biological psychiatry (1969), 2018-11, Vol.84 (9), p.644-654

2018

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(70)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent

Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study

First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm Clinical Studies

Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results

Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study

The Roles of Cbl-b and c-Cbl in Insulin-stimulated Glucose Transport

Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan

Identification of Steroid-Sensitive Gene-1/Ccdc80 as a JAK2-Binding Protein

Tu1607 A Randomized Comparison of Degradable Esophageal Stent Versus Dilation Therapy for Patients With Recurrent Benign Esophageal Strictures: 6-Month Results (Destiny Study)

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan

T-Cell Factor 4N (TCF-4N), a Novel Isoform of Mouse TCF-4, Synergizes with β-Catenin To Coactivate C/EBPα and Steroidogenic Factor 1 Transcription Factors

Floodplain Mapping in Response to Surface Mine Reclamation

T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors

Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark

Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals

Controlled Cationic Polymerization: Single-Component Initiation under Ambient Conditions

Management of Infants at Risk for Group B Streptococcal Disease

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium

Suchergebnisse filtern